The pregnant women living with hiv antiretroviral therapy coverage for pmtct in the Dominican Republic is now 58%, marking a 14% (31.8%) increase compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in the Dominican Republic
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
Similar regions to the Dominican Republic
More indicators for the Dominican Republic
Male unintentional poisoning
0.3
+0.0
(2021)
Female wasting in children
1.7%
-0.3%
(2019)
Female prevalence of HIV
0.4%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar288
+intl dollar50
(2022)
Birth registration
92.2%
+4.2%
(2019)
Contraceptive modern method prevalence
62%
-6.1%
(2019)
Dominican Republic PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | Value | Change |
|---|---|---|
| 2022 | 58% | +14% |
| 2021 | 44% | +17% |
| 2020 | 27% | -6% |
| 2019 | 33% | -6% |
| 2018 | 39% | -2% |
| 2017 | 41% | -4% |
| 2016 | 45% | +2% |
| 2015 | 43% | -8% |
| 2014 | 51% | +6% |
| 2013 | 45% | -14% |
| 2012 | 59% | +12% |
| 2011 | 47% | +14% |
| 2010 | 33% | -6% |
| 2009 | 39% | -3% |
| 2008 | 42% | +8% |
| 2007 | 34% | +9% |
| 2006 | 25% | +2% |
| 2005 | 23% | +10% |
| 2004 | 13% | +10% |
| 2003 | 3% | +1% |
| 2002 | 2% | +2% |
| 2001 | 0% | 0% |
| 2000 | 0% |